Could J147 be the next breakthrough for stroke patients?
NCT ID NCT07430917
First seen Feb 24, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This study tests whether the drug J147, given by IV along with standard clot-removal therapy, helps people recover better after an ischemic stroke. About 196 participants will receive either J147 or a placebo, and researchers will track safety, brain scans, and functional outcomes over 90 days. The goal is to see if J147 can reduce brain damage and improve recovery without serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dell Seton Medical Center at the University of Texas at Austin
Austin, Texas, 78712, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.